V12-06 FEMALE ORGAN-SPARING ROBOT-ASSISTED RADICAL CYSTECTOMY: TECHNIQUE AND INITIAL EXPERIENCE

Abstract

You have accessJournal of UrologyBladder Cancer & Urinary Diversion (V12)1 Apr 2020V12-06 FEMALE ORGAN-SPARING ROBOT-ASSISTED RADICAL CYSTECTOMY: TECHNIQUE AND INITIAL EXPERIENCE Ahmed Elsayed*, Hannah Ely, Naif Aldhaam, Yousuf Ramahi, Julian Joseph, Mohammad Durrani, Ahmed Hussein, and Khurshid Guru Ahmed Elsayed*Ahmed Elsayed* More articles by this author , Hannah ElyHannah Ely More articles by this author , Naif AldhaamNaif Aldhaam More articles by this author , Yousuf RamahiYousuf Ramahi More articles by this author , Julian JosephJulian Joseph More articles by this author , Mohammad DurraniMohammad Durrani More articles by this author , Ahmed HusseinAhmed Hussein More articles by this author , and Khurshid GuruKhurshid Guru More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000957.06AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Anterior pelvic exenteration is the standard of care for female patients with muscle invasive, as well as refractory non-muscle invasive bladder cancer. Female organ-sparing robot-assisted radical cystectomy (FsRARC) is a feasible option for selected patients. We hereby report the technique and initial perioperative outcomes of a FsRARC. METHODS: We identified 5 patients who underwent FsRARC for bladder cancer at Roswell Park Comprehensive Cancer Center. Demographics, perioperative and pathological outcomes were collated and reported. RESULTS: Mean age was 53 ± SD 19 years and mean body mass index was 26 ± SD 5. Median overall operative time was 391 minutes (IQR 361-429). Median estimated blood loss was 150 ml (IQR 120-250). All patients underwent intracorporeal urinary diversion and only one patient received a neobladder. Median hospital stay was 4 days (IQR 3-8). Median number of lymph nodes resected was 22 (IQR 18-35). One patient had ≥pT3, two had positive lymph nodes, and one patient had positive soft tissue surgical margin. One patient exhibited high grade complications and readmission. There were no perioperative reoperations, or mortality. At a median follow up of 7 months, only one patient had local pelvic recurrence. CONCLUSIONS: Female organ-sparing RARC seems feasible in select patients. Larger cohorts with longer follow up are required to ensure feasibility and oncologic safety. Source of Funding: Roswell Park Alliance Foundation © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1111-e1112 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Ahmed Elsayed* More articles by this author Hannah Ely More articles by this author Naif Aldhaam More articles by this author Yousuf Ramahi More articles by this author Julian Joseph More articles by this author Mohammad Durrani More articles by this author Ahmed Hussein More articles by this author Khurshid Guru More articles by this author Expand All Advertisement PDF downloadLoading ...